Sharing new approaches to translational research in non-small cell lung cancer

Oncologist

Volumn 5, Issue 6, 2000, Pages 514-519

  O'Brate, A ^a   Taron, M ^a   Gandara, D ^a   Rosell, R ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Non small cell lung cancer; Translational research

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CARBOPLATIN; CISPLATIN; DNA; DOCETAXEL; GEMCITABINE; IRINOTECAN; PLATINUM DERIVATIVE; PROTEIN P27; PROTEIN P53; TAXANE DERIVATIVE; TUBULIN;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; DNA MICROARRAY; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; INDIVIDUALIZATION; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; STOMACH CANCER; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0033669018     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.5-6-514     Document Type: Conference Paper

References (9)

1. Crossing the rubicon to the genomic era
2. Emerging therapies in NSCLC: Have we reached a 'chemotherapy efficacy plateau'?
3. A randomized phase II trial comparing rhumab VEGF (recombination humanized monoclonal antibody to vascular endothelial cell growth factor) plus carboplatin/paclitaxel (CP) to CP alone in patients with stage roB/IV NSCLC
4. Treatment sequencing, asymmetry, and uncertainty: Protocol strategies for combination chemotherapy
5. Tumor size, sensitivity to therapy, and design of treatment schedules
6. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy
7. Low thymidylate synthase and ERCC1 gene expressions are associated with increased survival after neoadjuvant 5-FU/cisplatin/radiotherapy for esophageal adenocarcinoma
8. Novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy
9. Chromosome 19 translocation, overexpression of Notch3, and human lung cancer